In this talk, Kara Palamountain will explain the inspiration for the design of the LYNX p24 Test, a new technology developed by the Northwestern Global Health Foundation (NWGHF) for early infant diagnosis of HIV. Approximately 1.4 million infants are born to HIV-infected women each year. Early testing of infants who have been exposed to HIV is essential for identifying infants who may be living with HIV, and for starting those infants on early, life-saving treatment. Without treatment, the mortality rate in HIV- infected infants can be as high as 45% by the first birthday and 59% by the second.
Kara Palamountain is the President of the Northwestern Global Health Foundation. She is also a Research Assistant Professor at the Kellogg School of Management and the Executive Director of the school’s Global Health Initiative (GHI). The GHI is currently working in partnership with NU’s Center for Innovation in Global Health Technologies (CIGHT) to develop and produce affordable HIV diagnostics for resource limited settings. Ms. Palamountain has played a crucial role in identifying the more strategic aspects of introducing diagnostics developed by CIGHT. She has managed over 50 Kellogg field research teams conducting market entry analysis in Botswana, Brazil, Cambodia, China, India, Mozambique, Namibia, South Africa, Tanzania, Uganda, Vietnam and Zambia.